Lisanti Capital Growth, LLC Halozyme Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$40.06 - $59.44 $5.9 Million - $8.76 Million	147,320 New	147,320 $8.38 Million
Q2 2022 Aug 03, 2022	BUY	$37.35 - $48.3 $13.1 Million - $17 Million	350,935 New	350,935 $15.4 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $10.2 Million - $13.5 Million	-263,460 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$39.51 - $51.45 $10.4 Million - $13.6 Million	263,460 New	263,460 $11 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.